I am new to this community. Has the community discussed this modality for treatment of Low and and intermediate risk PCa? If so- please direct me to the thread. TIA.
“The TACT study demonstrated that treatment with TULSA-PRO provides safe and effective prostate tissue ablation, with little impact on men’s functional ability compared to well-established treatment modalities such as radical prostatectomy and radiation therapy,“ said Dr. Christian Pavlovich, Director of Urologic Oncology at Johns Hopkins Bayview Medical Center. “The study also demonstrated a superior risk-benefit profile compared to other ablative approaches, including whole-gland HIFU and cryotherapy. Twelve months after TULSA, my patients are all doing well, are delighted with their quality of life, and do not have any residual GG2 or worse disease. I believe that based on these positive TACT results and the inherent flexibility of TULSA-PRO as a surgical tool, should clearance in the United States be obtained from the FDA, TULSA-PRO has the potential for quick acceptance and adoption by urologists.”
Source: April 04, 2019 19:45 ET | TORONTO, April 04, 2019 (GLOBE NEWSWIRE)